Wednesday, 2 July 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 2 July 2025
Ascott/Nuevo
Ascott/Nuevo
July notches seven PBS listings

There have been seven additions to the PBS this month, including two new medicines, a biosimilar, and four expansions for big brands. See whose drugs have made the cut.

Who's landed a new role?
The new financial year is barely days old but senior executives are already on the move. Find out who's snapped up a new role
TODAY
Weight loss drug finds new market
This approval means New Zealanders will be able to buy the latest wave of weight loss drugs, but out of their own pocket
TODAY
Two new Country Leaders named
Roche and GSK have each named General Managers for New Zealand, both flying in to take the reins from overseas roles
1 July
How generous was pharma in 2024?
Reports released by Medicines Australia reveals how much the industry donated last year, and where it directed the funds
1 July
AZ pulls breast cancer drug
Next gen drugs loom as three companies look to commercialise their candidates, with one already quietly approved by the TGA
30 June
Patient advocates call out 'slur'
It's a term often delivered with a sneer and patients have had enough with a top advocacy group demanding it be dropped
30 June
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (10)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Executive Roles (1)

Other (10)

AbbVie leaders roll up their sleeves
As part of the company's global volunteering month which saw over 130 ANZ staff support various organisations
1 July
Novo, Pfizer enter funding race
Two anti-TFPI antibodies plus a RET-altered cancer drug set to be considered by MSAC's sub-committee soon
1 July
Biogen's $10B bet approved
New Amgen drug plus the first biosimilar of a tyrosine kinase inhibitor also green-lighted by the TGA last week
30 June Approvals Action
Moderna knocks it out of the park
Company to file with regulators after results from a Phase 3 study showed its flu shot was superior to the competition
1 July
Who to watch in hot pharma space
Report outlines six companies in the radiopharma sector that are positioned to have an outsized impact
30 June
Lilly pulls presentation for top drug
Making room for a newer, multidose delivery option as the company overcomes supply issues in Australia
30 June
Aussies outshine global teams
Locals are stealing the international limelight muscling out global competitors to bring home coveted awards
27 June
Industry farewells 'true gentleman'
ICYMI: Tributes flow for well-known pharma exec after news of his death, aged 49 plus the other most popular stories this week
27 June Your Week in 5 Minutes
Who's winning the trials bonanza?
The number of clinical trials delivering results soared in 2024. See which pharmas area leading the pack
27 June
Red-hot rivals link up... for now
These two big pharmas are at commercial loggerheads but a quirk has thrown them together... with bumper results
27 June
Hunt clamps down on telehealth
Former Health Minister back in the spotlight unveiling draft national practice principles to ensure excellence in virtual care
27 June
TGA sues top news outlets
The regulator is going hard seeking financial penalties, alleging the parties have been warned on multiple occasions
26 June
Novo, Roche fake drugs seized
New warning for consumers to "exercise extreme caution" when purchasing medicines from unknown overseas websites
26 June
Boss draws roadmap to the C-suite
A new book describes the winding path to the top taken by one of Australia's most successful CEOs
26 June
PiF Jobs
PiF Jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.